Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
V Rotshild, B Hirsh-Raccah, I Miskin, M Muszkat… - Scientific reports, 2021 - nature.com
Abstract New Coronavirus Disease 2019 (COVID-19) vaccines are available to prevent the
ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. We …
ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. We …
Azithromycin in the treatment of COVID-19: a review
D Echeverría-Esnal, C Martin-Ontiyuelo… - Expert review of anti …, 2021 - Taylor & Francis
Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …
Antiviral and immunomodulatory agents have been proposed as potential treatments …
ACG clinical guideline: gastroparesis
Gastroparesis is characterized by symptoms suggesting retention of food in the stomach with
objective evidence of delayed gastric emptying in the absence of mechanical obstruction in …
objective evidence of delayed gastric emptying in the absence of mechanical obstruction in …
Update on the adverse effects of antimicrobial therapies in community practice
Objective To gather information about antibiotic side effects to be used as a reference and
learning resource for prescribing physicians. Quality of evidence A search of websites of …
learning resource for prescribing physicians. Quality of evidence A search of websites of …
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
A Pani, M Lauriola, A Romandini… - International journal of …, 2020 - Elsevier
The emergence of the new COVID-19 virus is proving to be a challenge in seeking effective
therapies. Since the most severe clinical manifestation of COVID-19 appears to be a severe …
therapies. Since the most severe clinical manifestation of COVID-19 appears to be a severe …
Risk evaluation of azithromycin‐induced QT prolongation in real‐world practice
Background. Azithromycin exposure has been reported to increase the risk of QT
prolongation and cardiovascular death. However, findings on the association between …
prolongation and cardiovascular death. However, findings on the association between …
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
Background Hydroxychloroquine and azithromycin combination therapy is often prescribed
for coronavirus disease 2019 (COVID-19). Electrocardiographic (ECG) monitoring is …
for coronavirus disease 2019 (COVID-19). Electrocardiographic (ECG) monitoring is …
Immunomodulation by macrolides: therapeutic potential for critical care
Critical illness is associated with immune dysregulation, characterised by concurrent
hyperinflammation and immune suppression. Hyperinflammation can result in collateral …
hyperinflammation and immune suppression. Hyperinflammation can result in collateral …
The gut microbiome and heart failure: a better gut for a better heart
M Branchereau, R Burcelin, C Heymes - Reviews in Endocrine and …, 2019 - Springer
Despite the development of new drugs and therapeutic strategies, mortality and morbidity
related to heart failure (HF) remains high. It is also the leading cause of global mortality …
related to heart failure (HF) remains high. It is also the leading cause of global mortality …
Efficacy and safety of COVID‐19 vaccines: A network meta‐analysis
AA Toubasi, TN Al‐Sayegh, YY Obaid… - Journal of Evidence …, 2022 - Wiley Online Library
Objective Several vaccines showed a good safety profile and significant efficacy against
COVID‐19. Moreover, in the absence of direct head to head comparison between COVID …
COVID‐19. Moreover, in the absence of direct head to head comparison between COVID …